Product Information
Registration Status: ActiveSIN14760P
FLUARIX TETRA SUSPENSION FOR INJECTION is approved to be sold in Singapore with effective from 2015-03-23. It is marketed by GLAXOSMITHKLINE PTE LTD, with the registration number of SIN14760P.
This product contains Monovalent Inactivated Split-Virion: A/H1N1 15mcg haemagglutinin/0.5ml,Monovalent Inactivated Split-Virion: A/H3N2 15mcg haemagglutinin/0.5ml,Monovalent Inactivated Split-Virion: B Strain (Victoria Lineage) 15mcg haemagglutinin/0.5ml, and Monovalent Inactivated Split-Virion: B Strain (Yamagata Lineage) 15mcg haemagglutinin/0.5ml in the form of INJECTION, SUSPENSION. It is approved for INTRAMUSCULAR use.
This product is manufactured by GlaxoSmithKline Biologicals in BELGIUM, Branch of SmithKline Beecham Pharma GmbH & Co. KG in FRANCE, andGlaxoSmithKline Biologicals SA in GERMANY.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.